← Leaderboards
Hans Haecker
St. Jude Children'S Research Hospital
$9,485,337
Attributed
$9,485,337
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,485,337 · 4
By mechanism
R01$9,485,337 · 4
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Jun J. Yang$13,116,250
Others in their field
Top investigators on “Biology”
- David Heimbrook · Leidos Biomedical Research, Inc.$731,505,112
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Lawrence Corey · Fred Hutchinson Cancer Center$543,202,300
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$480,487,534
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
BiologyToll-Like ReceptorsImmuneMolecularPathway InteractionsCellsMediatingAutoimmune DiseasesPreventReceptor ActivationBaseInflammationPathologyPathologicRecruitImmune ResponseProteinsBiochemicalMass Spectrum AnalysisPhenotypeInflammatoryFamilyAdaptor Signaling ProteinEvent
Grant awards (17)
A phospho-tyrosine-based signaling module controlling TLR-mediated inflammatory disease.$734,968
R01 · FY2025 · AI · contact PI
A phospho-tyrosine-based signaling module controlling TLR-mediated inflammatory disease.$734,968
R01 · FY2024 · AI · contact PI
A phospho-tyrosine-based signaling module controlling TLR-mediated inflammatory disease.$734,968
R01 · FY2023 · AI · contact PI
Pathogenic role of innate immune cells in lupus nephritis$447,517
R01 · FY2023 · AI · contact PI
A phospho-tyrosine-based signaling module controlling TLR-mediated inflammatory disease.$731,919
R01 · FY2022 · AI · contact PI
Pathogenic role of innate immune cells in lupus nephritis$447,517
R01 · FY2022 · AI · contact PI
Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation$515,751
R01 · FY2021 · AI · contact PI
Pathogenic role of innate immune cells in lupus nephritis$447,517
R01 · FY2021 · AI · contact PI
Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation$515,252
R01 · FY2020 · AI · contact PI
Pathogenic role of innate immune cells in lupus nephritis$444,467
R01 · FY2020 · AI · contact PI
Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation$814,380
R01 · FY2019 · AI · contact PI
Pathogenic role of innate immune cells in lupus nephritis$444,467
R01 · FY2019 · AI · contact PI
Discovery of small molecules inhibiting Toll-like receptor-mediated inflammation$812,562
R01 · FY2018 · AI · contact PI
TLR-mediated Signaling Complex Formation and Regulation of Effector Functions$411,642
R01 · FY2012 · AI · contact PI
TLR-mediated Signaling Complex Formation and Regulation of Effector Functions$411,642
R01 · FY2011 · AI · contact PI
TLR-mediated Signaling Complex Formation and Regulation of Effector Functions$415,800
R01 · FY2010 · AI · contact PI
TLR-mediated Signaling Complex Formation and Regulation of Effector Functions$420,000
R01 · FY2009 · AI · contact PI